Skip to main content
. 2018 Apr 30;8:6704. doi: 10.1038/s41598-018-25169-2

Figure 4.

Figure 4

Comparison of MGMT promoter methylation and protein expression with overall survival (OS) of patients. KM analyses of OS for MGMT promoter methylation (A,B) or MGMT protein expression (C,D) of Glioma treated (A,C) and untreated (B,D) with TMZ therapy.